Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants

British Journal of Haematology

Volumn 100, Issue 4, 1998, Pages 758-763

  Smith, F B ^a   Rumley, A ^b   Lee, A J ^a   Leng, G C ^a   Fowkes, F G R ^a   Lowe, G D O ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Fibrin D dimer; Fibrinogen; Intermittent claudication; Ischaemic heart disease; Stroke

Indexed keywords

D DIMER; FIBRINOGEN; GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

AGED; ARTERY DISEASE; ARTICLE; BLOOD VISCOSITY; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEMOSTASIS; HUMAN; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0031906556     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00626.x     Document Type: Article

References (33)

1. Al-Zahrani, H., Lowe, G.D.O., Douglas, J.T., Cuschieri, R., Pollock, J.G. & Smith, W.C.S. (1992) Increased fibrin turnover in peripheral arterial disease: comparison with a population study. Clinical Hemorrheology, 12, 867-872.
2. Antiplatelet Trialists' Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy. British Medical Journal, 308, 81-106.
3. Bainton, D., Sweetnam, P., Baker, I. & Elwood, P. (1994) Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. British Heart Journal, 72, 128-132.
4. Banerjee, A.K., Pearson, J., Gilliland, E.L., Goss, D., Lewis, J.D., Stirling, Y. & Meade, T.W. (1992) A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants. Thrombosis and Haemostasis, 68, 261-263.
5. Benderly, M., Graff, E., Reicher-Reiss, H., Behar, S., Brunner, D. & Goldbourt, U. (1996) Fibrinogen is a predictor of mortality in coronary heart disease patients. Arteriosclerosis, Thrombosis and Vascular Biology, 16, 351-356.
6. Cremer, P., Nagel, D., Böttcher, B. & Seidel, D. (1992) Fibrinogen: ein koronarer Risikofactor. Diagnose Labor, 42, 28-35.
7. Criqui, M.H., Coughlin, S.S. & Fronek, A. (1985) Non-invasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation, 72, 768-773.
8. Criqui, M.H., Langer, R.D., Fronek, A., Feigelson, U.S., Klauber, M.R., McCann, T.J. & Browner, D. (1992) Mortality over a period of 10 years in patients with intermittent claudication. New England Journal of Medicine, 326, 381-386.
9. Davey Smith, G., Shipley, M. & Rose, G. (1990) Intermittent claudication. heart disease risk factors and mortality: the Whitehall Study. Circulation, 82, 1925-1931.
10. Dormandy, J., Mahir, M., Ascady, G., Balsano, F., De Leeuw, P., Blombery, P. Bousser, MG., Clement, D., Coffmann, J., Deutshinoff, A., Bletry, O., Hampton, J., Mahler, F., Ohlin, P., Rieger, H., Stranden, E., Turpie, A.G.G., Urai, L. & Verstraete, M. (1989) Fate of the patient with chronic leg ischaemia. Journal of Cardiovascular Surgery, 50, 50-57.
11. Eliasson, M., Evrin, P-E. & Lundblad, D. (1994) Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: the Northern Sweden Monica Study. Journal of Clinical Epidemiology, 47, 513-524.
12. Folsom, A.R., Wu, K.K., Rosamond, W.D., Richey Sharett, A. & Chambless, L.E. (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 96, 1102-1108.
13. Fowkes, F.G.R., Lowe, G.D.O., Housely, E., Rattray, A., Rumley, A., Elton, R.A., MacGregor, I.R. & Dawes. J. (1993a) Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet, 342, 84-86.
14. Fowkes, F.G.R., Lowe, G.D.O., Rumley, A., Lennie, S.E., Smith, E.B. & Donnan, P.T. (1993b) The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years. European Heart Journal, 14, 597-601.
15. Gillum, R.F., Fortmann, S.P., Prinease, R.J. & Korrke, T.E. (1984) International diagnostic criteria for acute myocardial infarction and acute stroke. American Heart Journal, 108, 150-158.
16. Heinrich, J., Balleisen, L., Schulte, H., Assman, G. & Van de Loo, J. (1994) Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arteriosclerosis and Thrombosis, 15, 54-59.
17. Kannel, W.B., Wolf, P.A., Castelli, W.P. & D'Agostino, R.B. (1987) Fibrinogen and risk of cardiovascular disease: the Framingham study. Journal of the American Medical Association, 258, 1183-1186.
18. Lee, A.J., Fowkes, F.G.R., Lowe, G.D.O. & Rumley, A. (1995) Fibrin D-dimer, haemostatic factors and peripheral arterial disease. Thrombosis and Haemostasia, 74, 828-832.
19. Lee, A.I., Fowkes, F.G.R., Rattray, A., Rumley, A. & Lowe, G.D.O. (1996) Haemostatic factors and rheological factors in intermittent claudication: the influence of smoking and extent of disease. British Journal of Haematology, 92, 226-230.
20. Lowe, G.D.O. (1986) Blood rheology in arterial disease. Clinical Science, 71, 137-146.
21. Lowe, G.D.O., Fowkes, F.G.R., Dawes, J., Donnan, P.T., Lennie, S.E. & Housley. E. (1993) Blood viscosity, fibrinogen and activation of coagulation and leucocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation, 87, 1915-1920.
22. Lowe, G.D.O., Lee, A.J., Rumley, A., Price, J.F. & Fowkes, F.G.R. (1997) Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. British Journal of Haematology, 96, 168-173.
23. Meade, T.W., Mellows, S., Brozovic, M., Miller, G.J., Chakrabarti, R.R., North, W.C.S., Haines, A.P., Stirling, Y. Imeson, J.D. & Thompson, S.G. (1986) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet, ii, 533-537.
24. Miller, T.Q. (1994) High-risk studies are influenced by indirect range restriction. Journal of Behavioural Medicine, 17, 567-588.
25. Reunanen, A., Takkunen, H. & Aromaa, A. (1982) Prevalence of intermittent claudication and its effect on mortality. Acta Medica Scandinavica, 211, 249-256.
26. Rose, G.A. (1962) The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bulletin of the World Health Organisation, 27, 645-658.
27. Smith, F.B., Lee, A.J., Fowkes, F.G.R., Price, J.F. Rumley, A. & Lowe, G.D.O. (1997) Haemostatic factors as predictors of ischaemic heart disease and stroke in the Edinburgh Artery Study. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 3321-3325.
28. Smith, F.B., Lowe, G.D.O., Fowkes, F.G.R., Rumley, A., Rumley, A.G., Donnan, P.T. & Housley, E. (1993) Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis, 102, 155-162.
29. Stone, M.C. & Thorp, J.M. (1985) Plasma fibrinogen: a major risk factor. Journal of the Royal College of General Practice, 35, 565-569.
30. Sweetnam, P.M., Thomas, H.F., Yarnell, J.W.G., Beswick, A.D., Baker, I.A. & Elwood, P.C. (1996) Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. European Heart Journal, 17, 1814-1820.
31. Thompson, S.G., Kienast, J., Pyke, S.D.M., Haverkate, F. & van de Loo, J.C.W. (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New England Journal of Medicine, 332, 635-641.
32. Violi, F., Criqui, M., Longoli, A., Castiglioni, C., and the A.D.E.P. Group (1996) Relation between risk factors and cardiovascular complications in patients with peripheral arterial disease. Atherosclerosis, 120, 25-35.
33. Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L. & Tibblin, G. (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. New England Journal of Medicine, 311, 501-505.